Innovation in the 21st century: following the footsteps of Katalin Karikó

被引：0
作者：
Csaba Deák
Norbert Pardi
Ádám Miklósi
机构：
[1] University of Miskolc,Faculty of Materials and Chemical Engineering
[2] University of Pennsylvania,Department of Microbiology, Perelman School of Medicine
[3] ELKH-ELTE Comparative Ethology Research Group,Department of Ethology
[4] Eötvös Loránd University,undefined
来源：
Biologia Futura | 2023年 / 74卷
关键词：
mRNA vaccine; Katalin Karikó; Nucleoside-modification; Innovation; COVID-19; Evolution;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Innovation is a critical component of human society, setting us apart from other animals. We possess a unique capacity to design and produce new things through cultivating a culture that values and encourages innovation. One remarkable instance of innovation in the field of biology and medicine is the mRNA vaccine platform developed by Katalin Karikó and her colleagues. In this article, we delve into the evolution of mRNA-based therapy, beginning with animal models and concluding with the first clinical trials. The history of mRNA research began with the identification of its role in protein synthesis, leading to the development of mRNA vaccine technology. Karikó's pivotal innovation was discovering the need to integrate modified nucleosides into the mRNA, decreasing its recognition by the immune system. Her story offers valuable lessons, including the importance of market demand as a booster effect, the role of emerging technologies, the significance of universities and academic institutions in fostering innovation, the role of perseverance and faith, and the role of chance.
引用
收藏
页码：101 / 108
页数：7
相关论文
共 123 条
  • [11] Karikó K(1992)Reversal of diabetes insipidus in brattleboro rats: intra-hypothalamic injection of vasopressin mRNA Science 255 996-998
  • [12] Emri G(2013)A novel, disruptive vaccination technology: self-adjuvanted RNActive(®) vaccines Hum Vaccines Immunother 9 2263-2276
  • [13] Reményik E(1999)Overexpression of urokinase receptor in mammalian cells following administration of the Gene Ther 6 1092-1100
  • [14] Cobb M(2005) transcribed encoding mRNA Immunity 23 165-175
  • [15] Conry RM(2008)Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA Mol Ther 16 1833-1840
  • [16] LoBuglio AF(2011)Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability Nucleic Acids Res 39 e142-51
  • [17] Wright M(1985)Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA Sci Public Policy 13 44-6081
  • [18] Sumerel L(1989)Japanese innovation in mechatronics technology Proc Natl Acad Sci USA 86 6077-148
  • [19] Pike MJ(1985)Cationic liposome-mediated RNA transfection Proc Natl Acad Sci USA 82 144-7056
  • [20] Johanning F(1984)Injected anti-sense RNAs specifically block messenger RNA translation in vivo Nucl Acids Res 12 7035-1216
12345678910